Benefit of OTC Formula Against COVID-19 Is Explained by Selection Bias.
作者信息
Hemilä Harri
机构信息
Department of Public Health, 3835University of Helsinki, Helsinki, Finland.
出版信息
J Evid Based Integr Med. 2021 Jan-Dec;26:2515690X211058417. doi: 10.1177/2515690X211058417.
Abstract
摘要
相似文献
1
Benefit of OTC Formula Against COVID-19 Is Explained by Selection Bias.非处方配方对新冠病毒的益处是由选择偏倚解释的。
J Evid Based Integr Med. 2021 Jan-Dec;26:2515690X211058417. doi: 10.1177/2515690X211058417.
2
Benefit of OTC Formula Against COVID-19-Statistical Analysis Explained.非处方配方对新冠病毒的益处——统计分析解读
J Evid Based Integr Med. 2021 Jan-Dec;26:2515690X211058421. doi: 10.1177/2515690X211058421.
3
Preeclampsiada risk factor to get infected with COVID-19 or a selection bias?子痫前期是感染新冠病毒的风险因素还是选择偏倚？
Am J Obstet Gynecol. 2022 Jan;226(1):152. doi: 10.1016/j.ajog.2021.08.042. Epub 2021 Sep 2.
4
Did an effect of kidney transplantation on COVID-19 mortality go unnoticed due to selection bias?肾移植对新冠病毒疾病死亡率的影响是否因选择偏倚而未被注意到？
Transpl Int. 2021 May;34(5):773-775. doi: 10.1111/tri.13880.
5
Potential Biases in Studies of Acid-Suppressing Drugs and COVID-19 Infection.抑酸药物与新型冠状病毒肺炎感染研究中的潜在偏倚
Gastroenterology. 2021 Apr;160(5):1443-1446. doi: 10.1053/j.gastro.2020.11.053. Epub 2020 Dec 16.
6
Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19.提醒美国医生：DHEA（脱氢表雄酮）作为一种非处方雄激素补充剂被广泛使用，可能会使 COVID-19 恶化。
Endocr Relat Cancer. 2021 Feb;28(2):R47-R53. doi: 10.1530/ERC-20-0439.
7
Assessing and addressing collider bias in addiction research: the curious case of smoking and COVID-19.评估和解决成瘾研究中的对撞机偏差：吸烟与新冠疫情的奇特案例
Addiction. 2021 May;116(5):982-984. doi: 10.1111/add.15348. Epub 2021 Jan 20.
9
Preconception exposures and postconception outcomes: selection bias in action.孕前暴露与孕后结局：实际中的选择偏倚。
Fertil Steril. 2020 Dec;114(6):1172-1173. doi: 10.1016/j.fertnstert.2020.10.057.
10
Antiviral Activity of the Propylamylatin Formula against the Novel Coronavirus SARS-CoV-2 In Vitro Using Direct Injection and Gas Assays in Virus Suspensions.采用直接注射和气体检测法在病毒悬浮液中评估丙戊酰拉亭配方对新型冠状病毒 SARS-CoV-2 的抗病毒活性
Viruses. 2021 Mar 5;13(3):415. doi: 10.3390/v13030415.
本文引用的文献
1
20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment.20 周的非处方 COVID-19 预防和治疗的临床结果研究。
J Evid Based Integr Med. 2021 Jan-Dec;26:2515690X211026193. doi: 10.1177/2515690X211026193.
2
Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of randomized trial data.卡拉胶鼻喷可能使冠状病毒和流感病毒感染的康复率翻倍：随机试验数据再分析。
Pharmacol Res Perspect. 2021 Aug;9(4):e00810. doi: 10.1002/prp2.810.
3
Vitamin C May Increase the Recovery Rate of Outpatient Cases of SARS-CoV-2 Infection by 70%: Reanalysis of the COVID A to Z Randomized Clinical Trial.维生素C可能使新冠病毒感染门诊病例的康复率提高70%：对“新冠A到Z”随机临床试验的重新分析
Front Immunol. 2021 May 10;12:674681. doi: 10.3389/fimmu.2021.674681. eCollection 2021.
4
Vitamin C and COVID-19.维生素C与2019冠状病毒病
Front Med (Lausanne). 2021 Jan 18;7:559811. doi: 10.3389/fmed.2020.559811. eCollection 2020.
5
Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomized clinical trial: the Physicians' Health Study.一项随机临床试验中参与者与非参与者的基线特征及死亡经历比较：医师健康研究。
Control Clin Trials. 2002 Dec;23(6):686-702. doi: 10.1016/s0197-2456(02)00235-0.
Zotero 插件